The Division of Oncology was awarded the highest level of Green Office Certification from the WashU Office of Sustainability. Coordinated by the Office of Sustainability and endorsed by Resource Management, WashU’s Green Office Program aims to encourage offices across all WashU campuses to be champions of the university’s sustainability ethic.
Thomas Odeny, Assistant Professor of Medicine leads the Global Oncology Program in the Division of Oncology. He is the one of the scholars to receive a Robert A. Winn Diversity in Clinical Trials Award. His clinical research grant focuses on expanding clinical trials and treatment options for cancer in underrepresented people living with HIV in […]
John DiPersio, MD, PhD, Professor Medicine in the Division of Oncology will give the 2024 E Donnall Thomas lecture at the ASTCT/CIBMTR Tandem Meetings in San Antonio. The E. Donnall Thomas Lecture recognizes an eminent physician or scientist, either a clinician or an investigator, who has contributed meritoriously to the advancement of knowledge in blood […]
Melissa Reimers, Nikolaos Trikalinos, Kian-Huat Lim, Milan Chheda and Christopher Maher from the Division of Oncology received Siteman Investment Program funding for their research. Dr. Reimers, Associate Professor of Medicine, will assess the safety and tolerability of dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor used to treat diabetes and heart failure, in patients with high-risk […]
Cynthia Ma , lead author and Professor of Medicine in the Division of Oncology along with her colleagues Kiran Vij, Jeremy Hoog, Mark Watson and Erika Crouch in the Department of Pathology investigated the role of neoadjuvant anastrazole, fulvestrant or the combination in a multi-institutional trial. The trial did not find a benefit of fulvestrant […]
Dr. Fehniger, along with Alice Zhou (Division of Oncology), George Ansstas (Division of Oncology), and Ryan Fields (Department of Medicine) have received a $1.5 million grant to support a phase 1 trial of immunotherapy for melanoma. The study will treat patients with melanoma with natural killer cell-based therapy developed at Washington University for treatment of […]
Dr. Challen, Professor of Medicine in the Division of Oncology is a 2023 Leukemia & Lymphoma Society-Career Development Program Scholar Achievement Awardee. Dr. Challen’s laboratory research aims to determine how disruption of the chemical compounds that direct our genome leads to the development of blood cancers including important work in understanding how mutations in the […]
“Efforts to understand the molecular underpinnings of cancer took a giant leap forward fifteen years ago, when Ley et al. reported the first complete genome of a cancer — specifically, acute myeloid leukaemia (AML). Genomic data sets of this kind generated in the intervening years have revolutionized our knowledge about tumour biology.”
This collaborative study, published in Nature on Nov 1, 2023 involved researchers from the Divisions of Oncology, Department of Surgery, McDonnell Genome Institute, Siteman Cancer Center, Department of Radiation Oncology, Department of Neurologic Surgery, Department of Otolaryngology, Department of Obstetrics & Gynecology, and Department of Genetics at Washington University. Scientists discovered specific epigenetic changes that […]
Rigoberto De Jesus Pizarro and Joshua Siner, both third year Hematology-Oncology Fellows at Washington University School of Medicine are recipients of the 2023 Knowlton Incentive for Excellence Award. The awards recognize and support fellows who exemplify a compassionate spirit combined with outstanding knowledge and skill.Dr. Siner has clinical and research interests in classical hematology with […]